Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Phathom Pharmaceutical"


3 mentions found


While debate rages on about when the Federal Reserve might start cutting interest rates, biotech industry analysts are making the case that the argument for stocks in the sector is growing. Last week, Morgan Stanley analysts noted that it is the months leading up to an initial rate cut when biotech stocks outperform. Morgan Stanley also believes the case for biotech stocks is further reinforced by the financing environment and the outlook for mergers and acquisitions as well as upcoming innovation. The case for innovation Morgan Stanley also favors owning biotech stocks that have a strong drug platform even if the key catalyst of clinical trial data and FDA approvals are farther out. Rhythm ranks among the stocks rated overweight that Morgan Stanley favors in this category.
Persons: Morgan Stanley, Needham, Joseph Stringer, dealmaking, Stringer, erosive, it's, Phathom, GERD, LSEG, Merck, — CNBC's Michael Bloom Organizations: Federal Reserve, Nasdaq, Oncology, Immunology, Phathom Pharmaceutical, Pharmaceuticals, Phathom Pharmaceuticals, LSEG, Drug, Bristol Myers Squibb, Pfizer, Intellia Therapeutics, Rocket Pharmaceuticals Locations: New Jersey
Cramer's Lightning Round: Sell Phathom Pharmaceuticals
  + stars: | 2023-10-12 | by ( Julie Coleman | ) www.cnbc.com   time to read: +1 min
Stock Chart Icon Stock chart icon ChargePoint's year-to-date stock performance. Stock Chart Icon Stock chart icon Phathom Pharmaceuticals' year-to-date stock performance. Stock Chart Icon Stock chart icon Luminar Technologies' year-to-date stock performance. Stock Chart Icon Stock chart icon Taiwan Semiconductor's year-to-date stock performance. Stock Chart Icon Stock chart icon RTX's year-to-date stock performance.
Persons: that's, we're, Navitas, We're Organizations: Phathom Pharmaceuticals, Technologies, Luminar Technologies, Taiwan Semiconductor, Navitas Semiconductor Locations: Taiwan, China
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: Taiwan Semi looks like a buy, the only concern is China'Mad Money' host Jim Cramer weighs in on stocks including: ChargePoint, Phathom Pharmaceuticals, Luminar Technologies, Taiwan Semi, Axon Enterprise, Navitas Semiconductor, Biohaven LTD and RTX.
Persons: Jim Cramer Organizations: Phathom Pharmaceuticals, Luminar Technologies, Navitas Semiconductor, Biohaven Locations: Taiwan, China
Total: 3